Literature DB >> 33584191

Evaluation of Cerebral Blood Flow Measured by 3D PCASL as Biomarker of Vascular Cognitive Impairment and Dementia (VCID) in a Cohort of Elderly Latinx Subjects at Risk of Small Vessel Disease.

Kay Jann1, Xingfeng Shao1, Samantha J Ma1, Steven Y Cen2, Lina D'Orazio2, Giuseppe Barisano3, Lirong Yan1, Marlena Casey1, Jesse Lamas1, Adam M Staffaroni4, Joel H Kramer4, John M Ringman2, Danny J J Wang1,2.   

Abstract

Cerebral small vessel disease (cSVD) affects arterioles, capillaries, and venules and can lead to cognitive impairments and clinical symptomatology of vascular cognitive impairment and dementia (VCID). VCID symptoms are similar to Alzheimer's disease (AD) but the neurophysiologic alterations are less well studied, resulting in no established biomarkers. The purpose of this study was to evaluate cerebral blood flow (CBF) measured by 3D pseudo-continuous arterial spin labeling (pCASL) as a potential biomarker of VCID in a cohort of elderly Latinx subjects at risk of cSVD. Forty-five elderly Latinx subjects (12 males, 69 ± 7 years) underwent repeated MRI scans ∼6 weeks apart. CBF was measured using 3D pCASL in the whole brain, white matter and 4 main vascular territories (leptomeningeal anterior, middle, and posterior cerebral artery (leptoACA, leptoMCA, leptoPCA), as well as MCA perforator). The test-retest repeatability of CBF was assessed by intra-class correlation coefficient (ICC) and within-subject coefficient of variation (wsCV). Absolute and relative CBF was correlated with gross cognitive measures and domain specific assessment of executive and memory function, vascular risks, and Fazekas scores and volumes of white matter hyperintensity (WMH). Neurocognitive evaluations were performed using Montreal Cognitive Assessment (MoCA) and neuropsychological test battery in the Uniform Data Set v3 (UDS3). Good to excellent test-retest repeatability was achieved (ICC = 0.77-0.85, wsCV 3-9%) for CBF measurements in the whole brain, white matter, and 4 vascular territories. Relative CBF normalized by global mean CBF in the leptoMCA territory was positively correlated with the executive function composite score, while relative CBF in the leptoMCA and MCA perforator territory was positively correlated with MoCA scores, controlling for age, gender, years of education, and testing language. Relative CBF in WM was negatively correlated with WMH volume and MoCA scores, while relative leptoMCA CBF was positively correlated with WMH volume. Reliable 3D pCASL CBF measurements were achieved in the cohort of elderly Latinx subjects. Relative CBF in the leptomeningeal and perforator MCA territories were the most likely candidate biomarker of VCID. These findings need to be replicated in larger cohorts with greater variability of stages of cSVD.
Copyright © 2021 Jann, Shao, Ma, Cen, D’Orazio, Barisano, Yan, Casey, Lamas, Staffaroni, Kramer, Ringman and Wang.

Entities:  

Keywords:  arterial spin labeling; cerebral blood flow; cerebral small vessel disease; item response theory; vascular cognitive impairment and dementia; white matter hyperintensity

Year:  2021        PMID: 33584191      PMCID: PMC7873482          DOI: 10.3389/fnins.2021.627627

Source DB:  PubMed          Journal:  Front Neurosci        ISSN: 1662-453X            Impact factor:   4.677


  47 in total

1.  A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment.

Authors:  Laura E Gibbons; Adam C Carle; R Scott Mackin; Danielle Harvey; Shubhabrata Mukherjee; Philip Insel; S McKay Curtis; Dan Mungas; Paul K Crane
Journal:  Brain Imaging Behav       Date:  2012-12       Impact factor: 3.978

2.  User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability.

Authors:  Paul A Yushkevich; Joseph Piven; Heather Cody Hazlett; Rachel Gimpel Smith; Sean Ho; James C Gee; Guido Gerig
Journal:  Neuroimage       Date:  2006-03-20       Impact factor: 6.556

3.  Test-retest reliability and reproducibility of long-label pseudo-continuous arterial spin labeling.

Authors:  Tianye Lin; Jianxun Qu; Zhentao Zuo; Xiaoyuan Fan; Hui You; Feng Feng
Journal:  Magn Reson Imaging       Date:  2020-07-25       Impact factor: 2.546

4.  Vascular and Metabolic Factors in Alzheimer's Disease and Related Dementias: Introduction.

Authors:  Costantino Iadecola
Journal:  Cell Mol Neurobiol       Date:  2016-02-22       Impact factor: 5.046

5.  The value of arterial spin-labeled perfusion imaging in acute ischemic stroke: comparison with dynamic susceptibility contrast-enhanced MRI.

Authors:  Danny J J Wang; Jeffry R Alger; Joe X Qiao; Qing Hao; Samuel Hou; Rana Fiaz; Matthias Gunther; Whitney B Pope; Jeffrey L Saver; Noriko Salamon; David S Liebeskind
Journal:  Stroke       Date:  2012-02-09       Impact factor: 7.914

Review 6.  Cerebral blood flow in small vessel disease: A systematic review and meta-analysis.

Authors:  Yulu Shi; Michael J Thrippleton; Stephen D Makin; Ian Marshall; Mirjam I Geerlings; Anton J M de Craen; Mark A van Buchem; Joanna M Wardlaw
Journal:  J Cereb Blood Flow Metab       Date:  2016-08-05       Impact factor: 6.200

7.  Reliability of two-dimensional and three-dimensional pseudo-continuous arterial spin labeling perfusion MRI in elderly populations: comparison with 15O-water positron emission tomography.

Authors:  Emily Kilroy; Liana Apostolova; Collin Liu; Lirong Yan; John Ringman; Danny J J Wang
Journal:  J Magn Reson Imaging       Date:  2013-09-13       Impact factor: 4.813

8.  Characterization of lenticulostriate arteries with high resolution black-blood T1-weighted turbo spin echo with variable flip angles at 3 and 7 Tesla.

Authors:  Samantha J Ma; Mona Sharifi Sarabi; Lirong Yan; Xingfeng Shao; Yue Chen; Qi Yang; Kay Jann; Arthur W Toga; Yonggang Shi; Danny J J Wang
Journal:  Neuroimage       Date:  2019-05-31       Impact factor: 7.400

9.  Characterizing the white matter hyperintensity penumbra with cerebral blood flow measures.

Authors:  N Promjunyakul; D Lahna; J A Kaye; H H Dodge; D Erten-Lyons; W D Rooney; L C Silbert
Journal:  Neuroimage Clin       Date:  2015-04-22       Impact factor: 4.881

10.  Quantifying the test-retest reliability of cerebral blood flow measurements in a clinical model of on-going post-surgical pain: A study using pseudo-continuous arterial spin labelling.

Authors:  Duncan J Hodkinson; Kristina Krause; Nadine Khawaja; Tara F Renton; John P Huggins; William Vennart; Michael A Thacker; Mitul A Mehta; Fernando O Zelaya; Steven C R Williams; Matthew A Howard
Journal:  Neuroimage Clin       Date:  2013       Impact factor: 4.881

View more
  5 in total

Review 1.  Blood-Brain Barrier Dysfunction and the Potential Mechanisms in Chronic Cerebral Hypoperfusion Induced Cognitive Impairment.

Authors:  WenQing Xu; Qingke Bai; Qiang Dong; Min Guo; Mei Cui
Journal:  Front Cell Neurosci       Date:  2022-06-16       Impact factor: 6.147

Review 2.  Cerebral oxygen extraction fraction MRI: Techniques and applications.

Authors:  Dengrong Jiang; Hanzhang Lu
Journal:  Magn Reson Med       Date:  2022-05-05       Impact factor: 3.737

3.  Lacunar infarction aggravates the cognitive deficit in the elderly with white matter lesion.

Authors:  Wenjun Hu; Xing Guo; Yifeng Du
Journal:  Open Life Sci       Date:  2022-03-24       Impact factor: 0.938

4.  Effects of a 12-Week Periodized Resistance Training Program on Resting Brain Activity and Cerebrovascular Function: A Nonrandomized Pilot Trial.

Authors:  Timothy R Macaulay; Amy Hegarty; Lirong Yan; Dominique Duncan; Judy Pa; Jason J Kutch; Marianna La Rocca; Christianne J Lane; E Todd Schroeder
Journal:  Neurosci Insights       Date:  2022-08-13

5.  Sensitivity of Arterial Spin Labeling for Characterization of Longitudinal Perfusion Changes in Frontotemporal Dementia and Related Disorders.

Authors:  Tracy Ssali; Udunna C Anazodo; Lucas Narciso; Linshan Liu; Sarah Jesso; Lauryn Richardson; Matthias Günther; Simon Konstandin; Klaus Eickel; Frank Prato; Elizabeth Finger; Keith St Lawrence
Journal:  Neuroimage Clin       Date:  2021-10-07       Impact factor: 4.891

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.